LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi)…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
Moderna Announces FDA Advisory Committee Unanimously Votes in Support of Emergency Use for a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.
Positive unanimous vote for mRNA-1273 booster at the 50 µg dose level for individuals aged 65…
Arcosa, Inc. Announces Timing of Third Quarter 2021 Earnings Release and Conference Call
DALLAS–(BUSINESS WIRE)–Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions,…
United Rentals, Inc. Third Quarter 2021 Conference Call and Audio Webcast
Thursday, October 28, 2021 at 11:00 a.m. (ET) Dial-in numbers: Domestic: 855-458-4217; International: 574-990-3618 STAMFORD, Conn.–(BUSINESS…
UBS advisor Sherry Verburgt named to the Working Mother Magazine/SHOOK Research Top Wealth Advisor Moms list
HOUSTON–(BUSINESS WIRE)–UBS Wealth Management USA announced today that Sherry Verburgt, a Financial Advisor in the firm’s…
Astronics to Receive $24 Million in Cash from Combination of AMJP and Asset Sale
EAST AURORA, N.Y.–(BUSINESS WIRE)–Astronics Corporation (Nasdaq: ATRO), a leading provider of advanced technologies for global aerospace,…
PJT Partners Inc. to Report Third Quarter 2021 Financial Results and Host a Conference Call on October 26, 2021
NEW YORK–(BUSINESS WIRE)–PJT Partners Inc. (“PJT Partners”) (NYSE:PJT) announced that it expects to release its third…
Lazard to Announce Third-Quarter and Nine-Month 2021 Results
NEW YORK–(BUSINESS WIRE)–Lazard Ltd (NYSE: LAZ) will announce its third-quarter and nine-month 2021 results in a…
Quotient to Announce Third Quarter 2021 Financial Results on November 3, 2021
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Quotient (NYSE: QUOT), the leading digital media and promotions technology company, today announced…
BeiGene Announces BRUKINSA Approved for Treatment of Patients with Mantle Cell Lymphoma
Marks BRUKINSA’s second approved indication in Australia, on the heels of its recent initial approval in…